Hydroxychloroquine is a less-toxic metabolite of the antimalarial drug chloroquine and is used as an immunomodulator for the treatment of autoimmune diseases.
The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.
Computerized tomography scans of the chest are not a suitable independent screening tool for coronavirus-19 (COVID-19).
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
In a special article published online March 31 in JAMA Otolaryngology-Head & Neck Surgery, guidelines are presented for head and neck physical examination and associated procedures during the coronavirus disease 2019 (COVID-19) pandemic.
A summary of the current knowledge on the epidemiology, pathogenesis, and clinical characteristics of the SARS-CoV-2, which causes COVID-19, has been published.
Italy’s health care system is highly regarded, having more hospital beds per capita than the United States.
Data from patients with COVID-19 can be used to develop a model that can predict who will develop acute respiratory distress syndrome.
A new home-assessment approach to evaluate patients for SARS-CoV-2 was described, which enables safe evaluation and specimen collection outside of healthcare settings.
Three of 33 neonates born to mothers with coronavirus disease 2019 (COVID-19) in Wuhan tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).